About Us

About Us

Your therapy has the power to change lives. You bring the science — you shouldn’t have to be the expert in every step it takes to get it to patients.

Biopharma innovators face a daunting path: fragmented vendors, regulatory uncertainty, and the constant pressure to move faster without compromising quality. Every handoff between regulatory, clinical, and operational teams is a chance for momentum — and capital — to slip away.

Uniphar Development is your global development partner, guiding biopharma companies from pre-IND through approval. We bring integrated regulatory affairs, CMC, clinical pharmacology, clinical development, medical and scientific writing, and program management expertise under one roof, so the experts steering your program are already working in sync.

What that means for you:

• Move faster with fewer handoffs — integrated teams eliminate the gaps where timelines stall and costs climb.
• De-risk every milestone — seasoned regulatory and clinical strategists anticipate hurdles before they become setbacks.
• One partner, end to end — from pre-IND through approval, you get continuity instead of a relay race between vendors.
• Confidence at every decision point — clinical pharmacology and clinical development depth means your strategy is grounded in evidence, not guesswork.

You’ve done the hard work of the science. We help you carry it across the finish line — and into the hands of the patients waiting for it.

History

RRD was founded in 2002 to create an alternative approach to drug development, enabling more efficient use of capital and accelerating asset value whether it be human proof-of-concept (hPOC), or marketing approval.

Our expertise and experience spans the entire drug development process and combines rigorous scientific input, strategic insight, program management, and operational excellence to more rapidly achieve development milestones.

In 2020, RRD was acquired by Uniphar, a global diversified healthcare services company. The acquisition has enabled RRD to accelerate its growth through investment in its core development model as well as new capabilities that broaden RRD’s service offerings to its product development partners.

About Uniphar

Uniphar is a trusted global partner to pharma, medtech and biotech, delivering solutions that connect medicines and technologies with patients worldwide. With over 59 years of experience and partnerships with 200+ multinational clients, Uniphar combines deep expertise, global infrastructure and market insight to meet the evolving needs of the life sciences sector.

Uniphar Pharma integrates Development, Clinical, Access, Medical, Commercial, Distribution and Global Sourcing to support the full product lifecycle – from early-stage research through to commercialization and beyond. Uniphar’s unified platform spans regulatory strategy, clinical trial support, medical affairs, market access, patient engagement, commercial services, distribution and supply chain.

Operating across 180 countries with a global team of 3,500+, Uniphar bridges manufacturers, healthcare providers, and patients — accelerating access to innovative therapies, improving patient outcomes, and delivering value across the healthcare ecosystem.

From molecule to market and beyond.

For more information, visit Uniphar and Uniphar US.